Background Soluble HLA, Class I (S-HLA-I) has been found in serum, pla
sma, body fluids, peritoneal dialysates, and urine. S-HLA-I may be a p
roduct of membrane shedding, proteolysis, and/or alternate gene splici
ng. Previous assays to quantitate S-HLA-I were cumbersome, required ra
dioisotope labeling procedures, or the purification of Class I antigen
preceding antigen quantitation. The authors developed a solid-phase,
enzyme-linked immunoassay that can be used to quantitate S-HLA-I and t
o study its relevance in transplantation. Methods A solid-phase enzyme
-linked immunoassay employing monoclonal anti-Class I to catch S-HLA-I
present in plasma and peroxidase-labeled monoclonal anti-beta2-microg
lobulin (B2M) to quantitate bound S-HLA-I was employed. Values were co
rrelated with rejection and infection episodes. Pre- and postoperative
determinations were made from the sera of liver,9 heart,12 and kidney
20 recipients. Size chromatography was used to compare the molecular w
eight of S-HLA-I from baseline and peak serum concentrations obtained
during rejection episodes (2 liver, 1 heart, 1 kidney), and from 1 kid
ney recipient with a wound infection. Results All 9 liver recipients a
nd 12 heart recipients demonstrated a fall in S-HLA-I, or very low ini
tial values, for the first 10 days and then a progressive increase in
values substantially above preoperative concentrations. Values from re
nal recipients were more variable. There were temporary increases in S
-HLA-I preceding or during 16 of 20 (80%) biopsy-proven rejections (al
l reversible), and in 9 of 11 (83%) episodes of infection (bacterial,
viral, and fungal). In heart and liver rejection, as well as the wound
infection, the sera contained increased S-HLA-I, which was almost all
of the same molecular weight (approximately 52,000 daltons). In serum
from the one patient with renal rejection, two additional S-HLA-I pea
ks occurred, one with a molecular weight near 1,000,000 daltons and th
e second at a molecular weight approximately 11,000 daltons suggesting
cellular breakdown of the donor organ. Conclusion In summary, differe
nt patterns of S-HLA-I concentrations occur after kidney transplantati
on. Most liver and heart recipients reached a steady state higher than
preoperative levels. Transient increases in S-HLA-I occurred with rej
ection and infection. In one severe rejection episode, larger and smal
ler fractions of S-HLA-I were detected and may represent cell membrane
breakdown.